A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of PPV-06 Active Immunotherapy in Patients With Inflammatory Knee Osteoarthritis (KOA)
Latest Information Update: 30 Sep 2024
At a glance
- Drugs PPV-06 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Peptinov
- 30 Sep 2024 New trial record